Nicotinamide Mononucleotide Restores Pancreatic β-Cell Function in Type 2 Diabetes through SIRT6-HIF-1α-Mediated Mitochondrial Stress Adaptation and Glycolytic Reprogramming
This study demonstrates that Nicotinamide Mononucleotide (NMN) restores pancreatic β-cell function in Type 2 diabetes by activating the SIRT6-HIF-1α signaling axis to drive mitochondrial stress adaptation and glycolytic reprogramming, thereby alleviating hyperglycemia-induced cellular injury and preserving islet integrity.